[ Price : $8.95]
FDA approves an expanded use for Johnson & Johnsons Caplyta (lumateperone) as an adjunctive therapy with oral antidepressants in a...[ Price : $8.95]
Rep. Abe Hamadeh calls on FDA to suspend any enforcement actions against desiccated thyroid medications due to the possibility tha...[ Price : $8.95]
Addressing a Milken Institute annual summit, FDA commissioner Marty Makary reassures stakeholders that despite recent departures a...[ Price : $8.95]
Centessa Pharmaceuticals reports encouraging clinical data for its oral OX2R agonist ORX750 in patients with narcolepsy Types 1 an...[ Price : $8.95]
FDA warns Liebel-Flarsheim in Raleigh, NC, about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Alembic Pharmaceuticals active pharmaceutical ingre...[ Price : $8.95]
A STAT report highlighted in Medpage says CBER employees are concerned about the environment established by their new director, Vi...[ Price : $8.95]
FDA issues Biohaven a complete response letter, rejecting the companys NDA for Vyglxia (troriluzole) as a treatment for spinocereb...